News

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...
Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...
Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...
For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...
Service GLP-1 Medication Platform Offering Affordable Access to Semaglutide, Tirzepatide, and Phentermine with 24/7 Coaching, ...
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...
Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide ...